文献速递创面修复显微修复重建美容整形

人工真皮替代物用于桡前臂游离皮瓣供区修复的系统评价

The use of artificial dermal substitutes for repair of the donor site following harvesting of a radial forearm free flap: A systematic review.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-11-30

该系统评价检索Medline、Embase、Cochrane Library、Web of Science核心合集与Scopus,纳入8项非比较研究和11项比较研究,比较人工真皮替代物(ADM)与传统做法修复桡前臂游离皮瓣(RFFF)供区的美学与功能结局。11项比较研究中5项显示ADM在至少一项美学指标上优于对照,6项显示功能结局优于对照,无研究报告ADM结局更差;作者认为这些初步证据支持使用AlloDerm™、Integra™或Matriderm™,并指出需进一步开展包括随机对照试验在内的比较研究。

要点

  • 11项比较研究中5项至少一项美学指标优于对照,6项功能结局优于对照。
  • 无研究报告使用ADM后美学或功能结局劣于传统做法。
  • 作者认为累积效应方向支持使用AlloDerm™、Integra™或Matriderm™。

核心结论

  • 由于缺乏报告ADM结局劣于传统做法的研究且累积效应方向有利于ADM,作者认为这些证据强烈提示支持使用AlloDerm™、Integra™或Matriderm™。
  • 作者指出需进一步开展包括随机对照试验在内的比较研究以强化这些初步证据。

研究设计与样本

  • 系统评价,检索Medline、Embase、Cochrane Library、Web of Science核心合集与Scopus。
  • 纳入回顾性、前瞻性、病例对照研究与随机对照试验,涉及任何ADM。
  • 纳入标准为成年患者行RFFF切取并以ADM修复供区、报告适当临床结局且偏倚风险不高。
  • 因结局测量异质性妨碍Meta分析,对相关研究分组进行效应方向分析。
  • 纳入8项非比较研究,132例患者供区覆盖使用AlloDerm™、Integra™、Matriderm™或Rapiderm。

主要发现

  • 8项非比较研究中132例患者供区覆盖使用AlloDerm™、Integra™、Matriderm™或Rapiderm。
  • 11项比较研究中240例患者供区覆盖使用鱼皮基质、AlloDerm™、羊膜、MegaDerm™、Hyalomatrix、Integra™或Matriderm™。
  • 11项比较研究中5项根据至少一项美学指标显示ADM美学结局优于对照。
  • 11项比较研究中6项显示ADM功能结局优于对照。
  • 无研究报告ADM美学或功能结局劣于传统做法。

临床怎么用

  • 作者认为累积效应方向支持使用AlloDerm™、Integra™或Matriderm™修复RFFF供区。
  • 作者指出需进一步开展包括随机对照试验在内的比较研究以强化这些初步证据。

局限性

  • 结局测量存在异质性,妨碍进行Meta分析。
  • 作者指出需进一步开展包括随机对照试验在内的比较研究以强化这些初步证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Artificial dermal substitutes (ADMs) have been trialled to improve outcomes at the donor site following the harvesting of a radial forearm free flap (RFFF). This systematic review compares donor site aesthetic and functional outcomes, with the use of an ADM versus conventional practice. METHODS: The databases Medline, Embase, Cochrane Library, Web of Science (Core Collection), and Scopus were searched for retrospective, prospective, and case-control studies and randomised control trials (RCTs) involving any ADM. Studies with adult patients having undergone RFFF harvesting and donor site repair with an ADM, commenting on appropriate clinical outcomes and without high risk of bias, were included. Direction-of-effect analysis was performed on relevant groupings of studies since heterogeneity in outcome measurement precluded meta-analyses. RESULTS: Across eight non-comparative studies included, 132 patients had donor site coverage with AlloDerm™, Integra™, Matriderm™, or Rapiderm. Across 11 comparative studies included, 240 patients had donor site coverage with fish-skin matrix, AlloDerm™, amniotic membrane, MegaDerm™, Hyalomatrix, Integra™, or Matriderm™. Five out of 11 comparative studies demonstrated superior aesthetic outcomes with ADMs according to at least one aesthetic metric compared to controls, whilst 6/11 demonstrated superior functional outcomes with ADMs. No study demonstrated poorer aesthetic or functional outcomes with an ADM compared to conventional practice. CONCLUSIONS: In summary, the lack of studies reporting poorer outcomes with them compared to conventional practices, and a cumulative effect direction in their favour, provide strong indications in support of the use of AlloDerm™, Integra™, or Matriderm™ grafts. Further comparative studies, including RCTs, are needed to reinforce these initial indications.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Shah R, Rodrigues R, Phillips V, et al. The use of artificial dermal substitutes for repair of the donor site following harvesting of a radial forearm free flap: A systematic review. J Plast Reconstr Aesthet Surg. 2023. PMID: 38101265. doi:10.1016/j.bjps.2023.11.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。